QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms
QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms
Not yet recruiting · NCT07560449 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms | Malignant Plasma Cell Neoplasms | Not yet recruiting | Phase 2 | 2026-05-01 | NCT07560449 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qilu Pharmaceutical Co., Ltd. | 126 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||